These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 11025768

  • 1. The effect of halofuginone, an inhibitor of collagen type i synthesis, on urethral stricture formation: in vivo and in vitro study in a rat model.
    Nagler A, Gofrit O, Ohana M, Pode D, Genina O, Pines M.
    J Urol; 2000 Nov; 164(5):1776-80. PubMed ID: 11025768
    [Abstract] [Full Text] [Related]

  • 2. Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats.
    Bruck R, Genina O, Aeed H, Alexiev R, Nagler A, Avni Y, Pines M.
    Hepatology; 2001 Feb; 33(2):379-86. PubMed ID: 11172339
    [Abstract] [Full Text] [Related]

  • 3. The use of halofuginone in limiting urethral stricture formation and recurrence: an experimental study in rabbits.
    Jaidane M, Ali-El-Dein B, Ounaies A, Hafez AT, Mohsen T, Bazeed M.
    J Urol; 2003 Nov; 170(5):2049-52. PubMed ID: 14532851
    [Abstract] [Full Text] [Related]

  • 4. Halofuginone--an inhibitor of collagen type I synthesis--prevents postoperative formation of abdominal adhesions.
    Nagler A, Rivkind AI, Raphael J, Levi-Schaffer F, Genina O, Lavelin I, Pines M.
    Ann Surg; 1998 Apr; 227(4):575-82. PubMed ID: 9563549
    [Abstract] [Full Text] [Related]

  • 5. Growth inhibition of prostate cancer xenografts by halofuginone.
    Gavish Z, Pinthus JH, Barak V, Ramon J, Nagler A, Eshhar Z, Pines M.
    Prostate; 2002 May 01; 51(2):73-83. PubMed ID: 11948962
    [Abstract] [Full Text] [Related]

  • 6. The effect of halofuginone, a specific inhibitor of collagen type 1 synthesis, in the prevention of esophageal strictures related to caustic injury.
    Ozçelik MF, Pekmezci S, Saribeyoğlu K, Unal E, Gümüştaş K, Doğusoy G.
    Am J Surg; 2004 Feb 01; 187(2):257-60. PubMed ID: 14769315
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Halofuginone inhibits collagen deposition in fibrous capsules around implants.
    Olbrich KC, Meade R, Bruno W, Heller L, Klitzman B, Levin LS.
    Ann Plast Surg; 2005 Mar 01; 54(3):293-6;discussion 296. PubMed ID: 15725837
    [Abstract] [Full Text] [Related]

  • 13. Rapamycin inhibits formation of urethral stricture in rabbits.
    Chong T, Fu DL, Li HC, Zhang HB, Zhang P, Gan WM, Wang ZM.
    J Pharmacol Exp Ther; 2011 Jul 01; 338(1):47-52. PubMed ID: 21464336
    [Abstract] [Full Text] [Related]

  • 14. Halofuginone reduces the occurrence of renal fibrosis in 5/6 nephrectomized rats.
    Benchetrit S, Yarkoni S, Rathaus M, Pines M, Rashid G, Bernheim J, Bernheim J.
    Isr Med Assoc J; 2007 Jan 01; 9(1):30-4. PubMed ID: 17274353
    [Abstract] [Full Text] [Related]

  • 15. Prevention of esophageal strictures in a caustic burn model using halofuginone, an inhibitor of collagen type I synthesis.
    Arbell D, Udassin R, Koplewitz BZ, Ohana M, Genina O, Pines M, Nagler A.
    Laryngoscope; 2005 Sep 01; 115(9):1632-5. PubMed ID: 16148708
    [Abstract] [Full Text] [Related]

  • 16. Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis.
    Pines M, Knopov V, Genina O, Lavelin I, Nagler A.
    J Hepatol; 1997 Aug 01; 27(2):391-8. PubMed ID: 9288615
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of halofuginone on fibrosis formation secondary to experimentally induced subglottic trauma.
    Ertuğrul EE, Cincik H, Dogru S, Cekin E, Berber U, Gungor A, Poyrazoğlu IE.
    Laryngoscope; 2007 Feb 01; 117(2):299-302. PubMed ID: 17277625
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.